SCHEMBL13348672

SCHEMBL13348672

CSc1ccc2cncc(O)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
METAP2 P50579 1/20 0.35
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
NFKB1 P19838 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3243143 0.79 METAP2 (0.57) ALDH1A1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL13348658 0.73 ALDH1A1 (0.33) ALDH1A1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL13348670 0.71 ALDH1A1 (0.33) ALDH1A1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL13313429 0.67 KDM4E (0.45) ALDH1A1CYP1A2KDM4EMEN1NPC1
SCHEMBL13313428 0.67 PDE10A (0.36) ALDH1A1KDM4EMAPT
SCHEMBL13313432 0.67 CCR1 (0.55) ALDH1A1KDM4EMEN1NPC1LMNA
SCHEMBL13313431 0.67 KDM4E (0.61) ALDH1A1KDM4EMEN1LMNAMAPT
SCHEMBL13313430 0.67 SOS2 (0.61)
SCHEMBL23554440 0.65 ROCK2 (0.36) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL5800296 0.65 HTR1D (0.36) ALOX12KDM4ENPC1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2010-06-24 US disclosed
US-7692011-B2 8-hydroxy and 8-mercapto quinazolinones PRANA BIOTECHNOLOGY LIMITED (AU) 2010-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160346-A1 NEUROLOGICALLY ACTIVE COMPOUNDS ACHE, PSEN1, PSEN2 ALDH1A1 703/4885CYP1A2 1906/4885CYP3A4 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.